Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
/in Breast Cancer, Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2015-05-28 / Immunotherapy 2015;7(8):855-60Gastric cancer and the epoch of immunotherapy approaches
/in Dendritic Cells, Gastric Cancer, International Publications /von 2015-05-21 / World J. Gastroenterol. 2015 May;21(19):5778-93Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
/in Dendritic Cells, International Publications /von 2015-05-20 / Front Immunol 2015;6:243Advances in the understanding of cancer immunotherapy
/in Dendritic Cells, International Publications /von 2015-05-18 / BJU Int. 2015 Sep;116(3):321-9Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors
/in Dendritic Cells, International Publications /von 2015-05-01 / J. Immunother. 2015 May;38(4):155-64Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β
/in Dendritic Cells, International Publications /von 2015-04-17 / Eur. J. Immunol. 2015 Jun;45(6):1783-93Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2015-04-14 / Chonnam Med J 2015 Apr;51(1):1-7Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions
/in Dendritic Cells, International Publications /von 2015-04-12 / Cancer Immunol. Immunother. 2015 Jul;64(7):831-42Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2015-04-02 / Science 2015 May;348(6236):803-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de